Advertisement

Topics

Global Cancer Diagnostics Inc. Company Profile

02:47 EST 14th December 2018 | BioPortfolio

Global Cancer Diagnostics is a privately owned biotechnology company with an in-house medical diagnostic laboratory. The Company is located in Tempe, AZ. The Company provides the scientific and operating management resources to rapidly advance the development and introduction of this novel diagnostic technology into the domestic and global marketplace. For more information, visit the company’s Web site at www.GlobalCancerDx.com.


News Articles [2704 Associated News Articles listed on BioPortfolio]

Global Kidney Cancer Therapeutics & Diagnostics Market (2018-2023): Rising Number of Kidney Cancer Cases is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Kidney Cancer Therapeutics & Diagnostics Market – Segmented by Cancer Type, Therapy, Diagnostics, End-users, and Geography – Growt...

Prostate Cancer Diagnostics Market Size Worth $5.5 Billion by 2025: Grand View Research, Inc.

SAN FRANCISCO, November 6, 2018 /PRNewswire/ -- The global prostate cancer diagnostics market size is expected to reach USD 5.5 billion by 2025, according to Read more...

Global Prostate Cancer Diagnostics & Therapy Market Segmented by Type, Diagnosis, ...

ResearchAndMarkets.comLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call ...

How Sienna Cancer Diagnostics are translating telomerase into a cancer biomarker.

Cliff Holloway, CEO to Sienna Cancer Diagnostics, discusses the development and commercialisation of SCE-A7, the first telomerase detection product.

Global In-vitro Diagnostics Market Outlook to 2023: Advanced Technologies are Spurring Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global In-vitro Diagnostics Market – Segmented by Technique, Products, Usability, Application, End Users, and Geography – Growth, Trends, and ...

Personal Genome Diagnostics’ pan-cancer assay being used in new clinical trial

Personal Genome Diagnostics, Inc., a leader in cancer genomics and pioneer in liquid biopsy, today reported that its non-invasive, pan-cancer plasma assay is being used in an important new clinical tr...

Increasing Conditions and Diseases Drive Global POC Hematology Diagnostics Market

The global Point of Care (POC) hematology diagnostics market is expected to grow at a CAGR of close to 9%...

GENcast: Cancer Diagnostics and PD-L1

Microwave technology for peptide synthesis relies on company’s Liberty series of products. Methodology was designed to reduce reaction rates and waste production. The post GENcast: Cancer Diagnostic...

PubMed Articles [7109 Associated PubMed Articles listed on BioPortfolio]

A paradigm shift for prostate cancer diagnostics.

The current praxis of diagnosing prostate cancer, with systematic prostate biopsies in men with raised serum prostate-specific antigen (PSA) levels, leads to considerable over-diagnosis and over-treat...

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.

The increasing burden due to cancer and other noncommunicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development ...

Imaging biomarkers in oncology: Basics and application to MRI.

Cancer remains a global killer alongside cardiovascular disease. A better understanding of cancer biology has transformed its management with an increasing emphasis on a personalized approach, so-call...

Global DNA methylation profile in medullary thyroid cancer patients.

Changes in global DNA methylation have been suggested to cause genomic instability leading to increased risk of cancer. The accumulation of epigenetic changes is believed to contribute to tumorigenesi...

Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection.

Various recent studies have focused on analyzing tumor genetic material released into the blood stream, known as circulating tumor DNA (ctDNA). Herein, we describe current research on the application ...

Clinical Trials [9898 Associated Clinical Trials listed on BioPortfolio]

Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer

Quality of Life-Diagnostics and -Therapy in Individual Patients with Breast Cancer. A randomized study including 200 patients, 5 clinics and 43 general practitioners as coordinating docto...

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Non-Invasive Diagnostics of Small Renal Masses

NiSAR is a Ph.D. study and consists of three substudies. Renal cancer is one of the most deadly urologic malignancies and accounts for 900 new cases and 300 deaths per year. An increase in...

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Major Research Aim: To study novel molecular diagnostics and the pharmacokinetic variability among a spectrum of TB disease states, including severe forms of TB like disseminated TB, TB me...

Implementation of Quality of Life Diagnostics and Therapy

Implementation and Evaluation of Implementation of Quality of Life Diagnostics and Therapy in Individual Patients with Breast Cancer. A prospective study including 170 patients, 5 clinics ...

Companies [3200 Associated Companies listed on BioPortfolio]

Acuamark Diagnostics, Inc.

Acuamark Diagnostics is a biotechnology company focused on developing screening tests for blood-based early detection of cancer. Acuamark Diagnostics' technology allows for highly...

Global Cancer Diagnostics Inc.

Global Cancer Diagnostics is a privately owned biotechnology company with an in-house medical diagnostic laboratory. The Company is located in Tempe, AZ. The Company provides the ...

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology inves...

Fujirebio Diagnostics, Inc.

Fujirebio Diagnostics, Inc., a subsidiary of Fujirebio Holdings, Inc., is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. The company pi...

JFK Communications, Inc.

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and co...

More Information about "Global Cancer Diagnostics Inc." on BioPortfolio

We have published hundreds of Global Cancer Diagnostics Inc. news stories on BioPortfolio along with dozens of Global Cancer Diagnostics Inc. Clinical Trials and PubMed Articles about Global Cancer Diagnostics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Global Cancer Diagnostics Inc. Companies in our database. You can also find out about relevant Global Cancer Diagnostics Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record